Ospedale Oncologico A. Businco

Cagliari 09121

1 studies enrolling now · 3 studies all time

What they study most

Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Peripheral, Multiple Myeloma

Studies at this site

• Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation — Recruiting now
• BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL) — Completed
• T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma — Completed